CD133, which is neurospheres positive control, is associated with resistance to in vitro chemotherapy and therefore may relate G6PC3 (G6PCβ) and SLC37A4 (G6PT) to some chemoresistance and invasive molecular signature of GBM-derived CSC. The gene discussed is SLC37A4; the disease is glioblastoma.